• Study reports abnormally high VTE and high bleed risk in critically ill COVID-19 patients and calls for more effective prevention strategies.
  • Clinicians at NHS hospitals are supporting the care of COVID-19 patients with the use of geko™ devices to reduce the risk of blood clots in the most at risk patients.
Learn more Contact us

Wound therapy

Countess of Chester Hospital
NHS Foundation Trust

Accelerating closure of hard-to-heal complex wounds

Read Less

Following NICE guidance (MTG19)1 recommending use of the geko™ device for VTE prophylaxis, we have adopted the geko™ for high-risk VTE patients where drugs or other mechanical methods of VTE prevention are contraindicated or impractical.

Through targeted evaluations, I have also explored use of the geko™ in the healing process for patients with chronic venous insufficiency. Of note, was the introduction of geko™ as an adjunct therapy in the care regime of Mr Gordon Vickers, a patient with a hard-to-heal mixed aetiology ulcer, where pain and immobility had impacted the severity of his leg ulceration.

Hospitalized twice over a 6 month period, geko™ device usage was introduced at week 35 and controlled to 6 hours a day, five days a week. The combined geko™ + compression wound therapy delivered a significant reduction in the observed oedema and an accelerated wound healing process, resulting in total wound closure at week 23 post geko™ introduction2.

Mr Vickers treatment, also comprised of strong analgesia and antibiotics delivered intravenously, requiring hospital stays. Following geko™ use he reported improvements to quality of life and verbal pain rating, going from severe pain, to moderate, to low pain on treatment completion”.

Comment – Mr Vickers

“The geko™ was fitted above my compression bandage.  At that time, I was willing to try anything to help heal my wound. On discharge from hospital the nursing team thought I might never recover. My wound did though heal, and I was very pleased with how the geko™ device performed. I thought that my condition was irreparable but the geko™ device helped my recovery”.


Week 35

Prior to geko™ treatment.

Week 38

With geko™ treatment.

Week 58

Wound closed.


  1. NICE medical technologies guidance (MTG19). Published date: June 20 2014.
  2. Dimitri S, Pavey N, a targeted approach to healing complex wounds using the geko™ device, Firstkind Ltd, 2016.

OnPulse Technology

The revolutionary neuromuscular electrostimulation technology developed by Firstkind

Find out more

geko™ product

Wound Therapy Applications device

Find out more

Partner with us

What can the geko™ do for my patients?


Al Mahmoud Medical Center, Qatar, adopts the geko™ device for prevention of venous thromboembolism (VTE) and reduction of edema (swelling)


The geko™ device receives UK Conformity Assessed Mark

Social Media

Follow our social media channels to read our latest updates

Social Media